PaxVax Corporation researches, develops, manufactures, and commercializes vaccines against various infectious diseases. Its products include PXVX0200, Vivotif, Epaxal, PXVX0103 and Ad4-mGag. The company also engages in the research and development of vaccines against malaria, dengue, rabies, and herpes simplex virus. PaxVax Corporation was founded in 2006 and is based in Redwood City, California. It has R&D facilities in San Diego, California; and Thörishaus, Switzerland.